Prices delayed by at least 15 minutes | Prices updated on 30 May 2025, 17.40 BST | Print
Creo Medical Group PLC (CREO)
ORD GBP0.001This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Income statement
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal year ends | 31/12/2020 | 31/12/2021 | 31/12/2022 | 31/12/2023 | 31/12/2024 |
Turnover | 9 | 25 | 27 | 4 | 4 |
Expenses | 33 | 55 | 58 | 31 | 33 |
EBITDA | -22 | -27 | -28 | -23 | -26 |
EBIT | -23 | -30 | -31 | -26 | -29 |
Operating profit (reported) | -23 | -30 | -31 | -27 | -29 |
Operating profit (adjusted) | -18 | -20 | -21 | - | - |
Investment income | - | - | - | - | - |
Exceptional items | 0 | -0 | 0 | - | - |
Net interest | 0 | -0 | -0 | 1 | -0 |
Pre-tax profit | -23 | -30 | -31 | -26 | -29 |
Tax | -3 | -6 | -4 | -3 | -1 |
Net profit | -20 | -25 | -27 | -24 | -28 |
Minority interests | - | - | - | - | - |
Profit for financial year | -20 | -25 | -27 | -22 | -29 |
Ordinary dividends | - | - | - | - | - |
Retained profit | - | - | - | - | - |
Per share data | |||||
DPS p | - | - | - | - | - |
Normalized EPS p | -12.56 | -14.43 | -14.48 | -8.00 | -8.00 |
Reported EPS p | -12.55 | -14.48 | -14.48 | -8.00 | -8.00 |
Investment ratios | |||||
Operating margin | -2.49 | -1.19 | -1.13 | -6.73 | -7.20 |
DPS growth % | - | - | - | - | - |
Dividend cover x | - | - | - | - | - |
Norm EPS growth % | - | - | - | - | 0.00 |
Reported EPS growth % | - | - | - | - | - |
GBP in millions except per share data.